Asia Pacific Eubiotics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Asia-Pacific Eubiotics market has been segmented by type into probiotics, prebiotics, organic acids, and essential oils among others. Also, more than five demographics have been covered in the scope of the study.

Asia-Pacific Eubiotics Market

Asia-Pacific Eubiotics Market
Study Period: 2016 - 2026
Base Year: 2020
CAGR: 5.8 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The Asia-Pacific feed probiotics market was valued at USD 885.2 million in 2019 and is projected to witness a CAGR of 7.4% over the forecast period.   Development of research programs by local and global players are the major factors that are driving the growth of the market. Provita Eurotech Ltd, Life Products, Inc., Calpis Co. Ltd, Chr. Hansen A/S and Lallemand, Inc. are some of the major players operating in the market.​ Studies showed that Probiotics have enhanced the growth rate in broilers better than AGP (avilamycin) and other substitutes for AGP, such as phytochemicals, such as essential oils. Thus, increasing awareness pertaining to the nutritional benefits of probiotics is likely to further drive the Eubiotics market during the forecast period.

Scope of the report

Feed Eubiotics are considered to be the commercially-manufactured feed additive products that are used to enhance the characteristics such as weight gain, feed conversion ratio, and feed intake when fed in appropriate proportions. The feed Eubiotics that is accounted for in the commercial compound feed production has only been considered in the scope of the study.​

Type
Probiotics
Lactobacilli
Bifidobacteria
Other Probiotics
Prebiotics
Inulin
Fructo-Oligosaccharides
Galacto-Oligosaccharides
Other Prebiotics
Organic Acids
Essential Oils
Geography
Asia-Pacific
China
India
Indonesia
Thailand
Japan
South Korea
Australia
Rest of Asia-Pacific

Report scope can be customized per your requirements. Click here.

Key Market Trends

Yeast Derived Probiotic Supplemets to Drive the Eubiotics Market Growth

Yeast Probiotic fraction supplements have become a key focus area in improving gut functions at various levels such as intestinal microbiota stabilization, gut integrity improvement, and natural defense modulation. The ongoing field trials also highlighted the positive impact of yeast probiotics on the lactation phase of cattle, and swine alongside evidence of reduced treatment costs in livestock farming.​ As of March 2020, a field trial was conducted in concern with Bovine Respiratory Disease(BRD). A ban on antibiotics has promoted the alternative methods of research to treat this BRD. At a dosage rate of 5 grams per head per day, a cattle feedlot of 120 in total was treated with Actisaf Sc 47 and Safmannan, a yeast probiotic solution developed by Phileo Lesaffre Animal Care. The trial results signified the improved performance in terms of body weight by 1.5% and recovery from the morbidity and significantly reduced the treatment cost by 53.4%. ​Another field trial made by Lallemand as of February 2020, mentioned the improved performance of hyper prolific sows when treated with probiotic yeast, S. c. boulardii.Thus, innovating such novel solutions to enhance the cattle performance can be treated as a potential opportunity to find sustainable alternatives for antibiotics to improve animal performance in the years to come. ​

Asia-Pacific Eubiotics Market: Reduction of Treatment Costs, Probiotic Yeast(Actisaf Sc 47 and Safmannan), 2020​

China to Dominate the Eubiotics Market

China is one of the major players in the global feed probiotics industry, contributing around 50.80% revenue share in the Asia-Pacific probiotics market. The production of Eubiotics, especially probiotics for the aquaculture industry is a thriving sector in China. Lactobacillus is the most common variant of probiotic bacteria used in the aquafeed industry in China.  Owing to the African Swine Fever (ASF) outbreaks in China, the pig herds reduced significantly in 2018.  Slow herd replenishment, especially in the swine fever affected regions, is contributing to the near time shortfall and resulting in a decrease in swine feed in China.  The aforementioned trends vividly claim that the probiotics industry in China to be profoundly characterized by strong R&D investments focusing on product and regional expansion. Moreover, the increasing regulations, for instance, strict norms by the EU Commission and Food and Drug Administration(FDA), pertaining to the use of antibiotics in the feed industry is likely to further boost the feed Eubiotics market, over the forecast period in China.

Asia-Pacific Eubiotics Market: Revenue Share in %, China, 2020

Competitive Landscape

The market studied is highly fragmented and is dominated by Chr. Hansen A/S, DuPont de Nemours Inc., Koninklijke DSM NV, and Bluestar Adisseo Company. DuPont de Nemours Inc. and Chr. Hansen A/S, being the market leaders, cater to a wider range of product offerings and have a strong geographical presence, providing a competitive advantage in the market. The continuous growth in the revenue generation is further assisting the market's growth. The market leaders, such as Chr. Hansen, are offering a wider range of feed probiotics, including BIOPLUS® YC, GALLIPRO®, GALLIPRO® Tect, and BOVAMINE® Dairy, catering to a surplus range of animals, including the swine, poultry, and dairy industries. Moreover, the company accounted for 22% of the share of the Health and Nutrition sector in 2018. ​

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions & Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

    3. 4.3 Market Restraints

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Bargaining Powers of Buyers

      2. 4.4.2 Bargaining Powers of Suppliers

      3. 4.4.3 Threat of New Entrants

      4. 4.4.4 Threat of Substitutes

      5. 4.4.5 Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 Type

      1. 5.1.1 Probiotics

        1. 5.1.1.1 Lactobacilli

        2. 5.1.1.2 Bifidobacteria

        3. 5.1.1.3 Other Probiotics

      2. 5.1.2 Prebiotics

        1. 5.1.2.1 Inulin

        2. 5.1.2.2 Fructo-Oligosaccharides

        3. 5.1.2.3 Galacto-Oligosaccharides

        4. 5.1.2.4 Other Prebiotics

      3. 5.1.3 Organic Acids

      4. 5.1.4 Essential Oils

    2. 5.2 Geography

      1. 5.2.1 Asia-Pacific

        1. 5.2.1.1 China

        2. 5.2.1.2 India

        3. 5.2.1.3 Indonesia

        4. 5.2.1.4 Thailand

        5. 5.2.1.5 Japan

        6. 5.2.1.6 South Korea

        7. 5.2.1.7 Australia

        8. 5.2.1.8 Rest of Asia-Pacific

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Most Adopted Strategies

    2. 6.2 Market Share Analysis

    3. 6.3 Company Profiles

      1. 6.3.1 Life Products, Inc

      2. 6.3.2 Calpis Co. Ltd

      3. 6.3.3 Chr. Hansen A/S

      4. 6.3.4 Lallemand, Inc.

      5. 6.3.5 Danisco A/S

      6. 6.3.6 DSM Nutritional Products, Inc.

      7. 6.3.7 Orffa International Holding B.V.

      8. 6.3.8 Novus International, Inc.

      9. 6.3.9 Kemin Industries, Inc.

      10. 6.3.10 Biovet Joint Stock Company

      11. 6.3.11 Biomin Holding GmbH

      12. 6.3.12 Bluestar Adisseo Company

  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

  8. 8. IMPACT OF COVID-19

**Subject to Availability

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Asia Pacific Eubiotics Market market is studied from 2016 - 2026.

The Asia Pacific Eubiotics Market is growing at a CAGR of 5.8% over the next 5 years.

DSM Nutritional Products, Inc., Novus International, Inc., Kemin Industries, Bluestar Adisseo Company, Lallemand, Inc. are the major companies operating in Asia Pacific Eubiotics Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!